Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
245.72
-0.31 (-0.13%)
At close: Nov 13, 2026, 4:00 PM EST
246.75
+1.03 (0.42%)
After-hours: Nov 13, 2026, 7:30 PM EST

Glaukos Revenue

Glaukos had revenue of $211.03M in the quarter ending September 30, 2026, with 58.03% growth. This brings the company's total for the last twelve months to $690.33M, up 46.94% year-over-year. In the year 2025, Glaukos had annual revenue of $507.44M with 32.33% growth. That makes Glaukos the 9,475th largest company in the world by revenue and 2,077th in the United States.

Revenue (ttm)
$690.33M
Revenue Growth
+46.94%
P/S Ratio
21.06
Revenue / Employee
$631,016
Employees
1,094
Market Cap
14.54B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Glaucoma 421.07M 83.0%
  • Corneal Health 86.37M 17.0%

By Geography

Chart
  • United States 375.04M 73.9%
  • International 132.40M 26.1%
Fiscal year ended Dec 31, 2025 See the full Glaukos breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025507.44M123.96M32.33%
Dec 31, 2024383.48M68.77M21.85%
Dec 31, 2023314.71M31.85M11.26%
Dec 31, 2022282.86M-11.15M-3.79%
Dec 31, 2021294.01M69.05M30.70%
Dec 31, 2020224.96M-12.03M-5.07%
Dec 31, 2019236.98M55.71M30.73%
Dec 31, 2018181.28M22.02M13.83%
Dec 31, 2017159.25M44.86M39.21%
Dec 31, 2016114.40M42.70M59.55%
Dec 31, 201571.70M26.11M57.28%
Dec 31, 201445.59M24.64M117.64%
Dec 31, 201320.95M18.52M762.33%
Dec 31, 20122.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.